Covered recipient · General Payments record
SARIYA ZAIN SIDDIQI
Allopathic & Osteopathic Physicians Family Medicine Geriatric Medicine
General Payments · PY2019–2024
$1,163.37
- Reported across 21 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,001.82 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $326.24 | 6 |
| Acerta Pharma LLC | $239.60 | 2 |
| Lilly USA, LLC | $197.02 | 4 |
| Madrigal Pharmaceuticals | $118.16 | 1 |
| ABBVIE INC. | $43.95 | 2 |
| QOL Medical, LLC | $40.00 | 2 |
| PFIZER INC. | $36.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.67 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106097143 | CMS |
| ABBVIE INC. | $21.28 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106097145 | CMS |
| AstraZeneca Pharmaceuticals LP | $119.23 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104229443 | CMS |
| AstraZeneca Pharmaceuticals LP | $120.37 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104549222 | CMS |
| Lilly USA, LLC | $120.89 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135418521 | CMS |
| Lilly USA, LLC | $24.83 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135392411 | CMS |
| Lilly USA, LLC | $20.48 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135418523 | CMS |
| Lilly USA, LLC | $30.82 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135378552 | CMS |
| Madrigal Pharmaceuticals | $118.16 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144182557 | CMS |
| Novo Nordisk Inc | $20.39 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096907803 | CMS |
| Novo Nordisk Inc | $19.88 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096912126 | CMS |
| Novo Nordisk Inc | $124.45 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097707350 | CMS |
| Novo Nordisk Inc | $18.27 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097299428 | CMS |
| Novo Nordisk Inc | $120.89 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097697264 | CMS |
| Novo Nordisk Inc | $22.36 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097729067 | CMS |
| PFIZER INC. | $36.85 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131187893 | CMS |
| QOL Medical, LLC | $19.81 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147711420 | CMS |
| QOL Medical, LLC | $20.19 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147711422 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2024
- Source files
- Dataset page · Bulk file · PY2019 , PY2022 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.